CLOV - MSCI adds ZOM CLOV 110 others to US Micro Cap Index MNKD SAVA to be deleted
MSCI will be including total 112 companies including Zomedica (NYSE:ZOM), Clovis Oncology (NASDAQ:CLOV), 22nd Century (NASDAQ:XXII), Omeros (NASDAQ:OMER) and Verastem (NASDAQ:VSTM) in its MSCI US Micro Cap Index as a part of Semi-Annual Index Review. MSCI excluded a total of 9 securities from its index. Healthcare dominated the exclusion list with MannKind (NASDAQ:MNKD), Cassava Sciences (NASDAQ:SAVA), Peabody Energy (NYSE:BTU), Celldex Therapeutics (NASDAQ:CLDX) and Ocular Therapeutics (NASDAQ:OCUL). All changes will be implemented as of the close of November 30, 2021. Press Release
For further details see:
MSCI adds ZOM, CLOV, 110 others to US Micro Cap Index, MNKD, SAVA to be deleted